José Carlos Aidar Ayoub

Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019

Dalton Bertolim Précoma, Gláucia Maria Moraes de Oliveira, Antônio Felipe Leite Simão et al. · Arquivos Brasileiros de Cardiologia · 2019 · 431 citations · Full text

Medicine, Cardiology, Preventive Medicine +17

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Kausik K Ray, Helen M Colhoun, Michael Szarek et al. · The Lancet Diabetes & Endocrinology · 2019 · 328 citations · Full text

Medicine, Cardiology, Internal Medicine +15

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

Gregory G. Schwartz, Vera A. Bittner, Patricio López‐Jaramillo et al. · Journal of the American College of Cardiology · 2021 · 141 citations · Full text

Medicine, Cardiology, Pharmacology +17

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 122 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effects of blood pressure and lipid lowering on cognition

Jackie Bosch, Martin O’Donnell, Balakumar Swaminathan et al. · Neurology · 2019 · 82 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14